Freedom Broker Maintains Buy on Lifevantage, Lowers Price Target to $8

Benzinga · 1d ago
Freedom Broker analyst Ilya Zubkov maintains Lifevantage (NASDAQ:LFVN) with a Buy and lowers the price target from $9 to $8.